Profiles

Keywords
Last Name
Institution

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Paul Carvey and Christopher Goetz.

 
Connection Strength
 
 
 
1.279
 
  1. Goetz CG, Pappert EJ, Blasucci LM, Stebbins GT, Ling ZD, Nora MV, Carvey PM. Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations. Neurology. 1998 Feb; 50(2):515-7.
    View in: PubMed
    Score: 0.220
  2. Goetz CG, Klawans HL, Carvey P. Animal models of tardive dyskinesia: their use in the search for new treatment methods. Mod Probl Pharmacopsychiatry. 1983; 21:5-20.
    View in: PubMed
    Score: 0.077
  3. Kompoliti K, Adler CH, Raman R, Pincus JH, Leibowitz MT, Ferry JJ, Blasucci L, Caviness JN, Leurgans S, Chase WM, Yones LC, Tan E, Carvey P, Goetz CG. Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics. Neurology. 2002 May 14; 58(9):1418-22.
    View in: PubMed
    Score: 0.074
  4. Goetz CG, Carvey PM, Pappert EJ, Vu TQ, Leurgans SE. The role of the serotonin system in animal models of myoclonus. Adv Neurol. 2002; 89:244-8.
    View in: PubMed
    Score: 0.072
  5. Goetz CG, Vu TQ, Carvey PM, Leurgans S. Posthypoxic myoclonus in the rat: natural history, stability, and serotonergic influences. Mov Disord. 2000; 15 Suppl 1:39-46.
    View in: PubMed
    Score: 0.063
  6. Pappert EJ, Goetz CG, Vu TQ, Ling ZD, Leurgans S, Raman R, Carvey PM. Animal model of posthypoxic myoclonus: effects of serotonergic antagonists. Neurology. 1999 Jan 01; 52(1):16-21.
    View in: PubMed
    Score: 0.059
  7. Pappert EJ, Goetz CG, Stebbins GT, Belden M, Carvey PM. 5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes. Eur J Pharmacol. 1998 Apr 17; 347(1):51-6.
    View in: PubMed
    Score: 0.056
  8. Pappert EJ, Lipton JW, Goetz CG, Ling ZD, Stebbins GT, Carvey PM. The stability of carbidopa in solution. Mov Disord. 1997 Jul; 12(4):608-10.
    View in: PubMed
    Score: 0.053
  9. Pappert EJ, Goetz CG, Niederman F, Ling ZD, Stebbins GT, Carvey PM. Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation. Neurology. 1996 Dec; 47(6):1493-5.
    View in: PubMed
    Score: 0.051
  10. Pappert EJ, Tangney CC, Goetz CG, Ling ZD, Lipton JW, Stebbins GT, Carvey PM. Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels. Neurology. 1996 Oct; 47(4):1037-42.
    View in: PubMed
    Score: 0.050
  11. Pappert EJ, Buhrfiend C, Lipton JW, Carvey PM, Stebbins GT, Goetz CG. Levodopa stability in solution: time course, environmental effects, and practical recommendations for clinical use. Mov Disord. 1996 Jan; 11(1):24-6.
    View in: PubMed
    Score: 0.048
  12. Goetz CG, Thelen JA, MacLeod CM, Carvey PM, Bartley EA, Stebbins GT. Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exercise. Neurology. 1993 May; 43(5):1040-2.
    View in: PubMed
    Score: 0.040
  13. Carvey PM, Ptak LR, Nath ST, Sierens DK, Mufson EJ, Goetz CG, Klawans HL. Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures. Exp Neurol. 1993 Mar; 120(1):149-52.
    View in: PubMed
    Score: 0.039
  14. Carvey PM, Ptak LR, Lo ES, Lin DH, Buhrfiend CM, Goetz CG, Klawans HL. Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures. Exp Neurol. 1991 Oct; 114(1):28-34.
    View in: PubMed
    Score: 0.035
  15. Carvey PM, McRae A, Lint TF, Ptak LR, Lo ES, Goetz CG, Klawans HL. The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease. Neurology. 1991 May; 41(5 Suppl 2):53-8; discussion 59-60.
    View in: PubMed
    Score: 0.034
  16. Carvey PM, McRae A, Ptak LR, Kao LC, Lo ES, Goetz CG, Tanner CM, Penn RD, Klawans HL. Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor. Prog Brain Res. 1990; 82:693-7.
    View in: PubMed
    Score: 0.031
  17. McRae-Degueurce A, Klawans HL, Penn RD, Dahlstrom A, Tanner CM, Goetz CG, Carvey PM. An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation. Neurosci Lett. 1988 Nov 22; 94(1-2):192-7.
    View in: PubMed
    Score: 0.029
  18. Goetz CG, Tanner CM, Shannon KM, Carroll VS, Klawans HL, Carvey PM, Gilley D. Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations. Neurology. 1988 Jul; 38(7):1143-6.
    View in: PubMed
    Score: 0.028
  19. Carvey PM, Hitri A, Goetz CG, Tanner CM, Klawans HL. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation. Life Sci. 1988; 42(22):2207-15.
    View in: PubMed
    Score: 0.027
  20. Klawans HL, Carvey PM, Nelson D, Tanner CM, Goetz CG. The effect of thioridazine on haloperidol induced behavioral hypersensitivity. Life Sci. 1986 May 12; 38(19):1707-14.
    View in: PubMed
    Score: 0.024
  21. Carvey PM, Kao LC, Tanner CM, Goetz CG, Klawans HL. The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivity. Eur J Pharmacol. 1986 Jan 21; 120(2):193-9.
    View in: PubMed
    Score: 0.024
  22. Klawans HL, Carvey PM, Tanner CM, Goetz CG. Drug-induced myoclonus. Adv Neurol. 1986; 43:251-64.
    View in: PubMed
    Score: 0.024
  23. Carvey P, Paulseth JE, Goetz CG, Klawans HL. L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update. Adv Neurol. 1986; 43:509-17.
    View in: PubMed
    Score: 0.024
  24. Klawans HL, Carvey P, Tanner CM, Goetz CG. The pathophysiology of tardive dyskinesia. J Clin Psychiatry. 1985 Apr; 46(4 Pt 2):38-41.
    View in: PubMed
    Score: 0.023
  25. Goetz CG, Carvey PM, Tanner CM, Klawans HL. Neuroleptic-induced dopamine hyposensitivity. Life Sci. 1984 Apr 09; 34(15):1475-9.
    View in: PubMed
    Score: 0.021
  26. Klawans HL, Goetz CG, Carvey P. Animal models of tardive dyskinesias. Clin Neuropharmacol. 1983 Jun; 6(2):129-35.
    View in: PubMed
    Score: 0.020
  27. Kompoliti K, Goetz CG, Vu TQ, Carvey PM, Leurgans S, Raman R. Estrogen supplementation in the posthypoxic myoclonus rat model. Clin Neuropharmacol. 2001 Jan-Feb; 24(1):58-61.
    View in: PubMed
    Score: 0.017
  28. Shults CW, O'Connor DT, Baird A, Hill R, Goetz CG, Watts RL, Klawans HL, Carvey PM, Bakay RA, Gage FH, et al. Clinical improvement in parkinsonian patients undergoing adrenal to caudate transplantation is not reflected by chromogranin A or basic fibroblast growth factor in ventricular fluid. Exp Neurol. 1991 Mar; 111(3):276-81.
    View in: PubMed
    Score: 0.009
  29. Weiner WJ, Carvey P, Nausieda PA, Goetz CG, Klawans HL. Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig. Adv Neurol. 1982; 35:213-9.
    View in: PubMed
    Score: 0.005
  30. Weiner WJ, Carvey P, Nausieda PA, Goetz CG, Klawans HL. The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig. Life Sci. 1981 May 11; 28(19):2173-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.